Hengrui Medicine: Subsidiary Approved for Listing of Eicosapentaenoic Acid Ethyl Ester Soft Capsules

Hengrui Pharmaceuticals announced that its subsidiary Chengdu Shengdi Pharmaceuticals has received a notification from the National Medical Products Administration approving the listing of the company's Eicosapentaenoic Acid Ethyl Ester Soft Capsules. This drug is used to lower the levels of severe hypertriglyceridemia in adult patients and is used in combination with statins to reduce cardiovascular event risk.